KOSDAQRetail & Consumer043710

CosLeaguer Global

₩3,285▲ 0.61%2026-11-18 close
Market Cap
₩56.9B
Turnover
₩18,114,540
Volume
5.5K
Shares out.
17.3M
PER
—
PBR
2.1×
EPS
-₩700
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Revenue up three straight quarters, profit swings quarter to quarter

CosLeaguer Global is restructuring around cosmetics ODM manufacturing and brands. Revenue has risen for three straight quarters through the third quarter of 2026, while operating results have swung between profit and loss from quarter to quarter.

  1. 1

    Revenue in 2025 was KRW 35.7 billion, up 84.4% from the prior year and the largest year in the 2022–2025 period. Compared with KRW 10.1 billion in 2022, the top line has expanded substantially.

  2. 2

    The company has recorded an operating loss in each year from 2022 to 2025. The 2025 operating loss of KRW 8.33 billion widened again from 2024.

  3. 3

    Operating profit turned positive in the first quarter of 2026 at KRW 1.55 billion and returned to profit in the third quarter at KRW 2.73 billion. The second quarter posted an operating loss of KRW 600 million.

  4. 4

    The debt-to-equity ratio reached 476.6% at the end of 2025, up sharply from 28.4% in 2024. Total liabilities were KRW 187.2 billion against total equity of KRW 39.3 billion.

  5. 5

    The business has been reorganized around cosmetics, with an ODM subsidiary established at the end of December 2024 and a brand company acquired in 2025. The company has set a 2026 consolidated revenue target of KRW 200 billion.

02

Business structure

CosLeaguer Global was founded in 1991 and listed on KOSDAQ in 2002. Its shareholders approved a name change from SEOULEAGUER to CosLeaguer Global on March 27, 2026, effective May 4, 2026. The business has three arms: cosmetics manufacturing, cosmetics brands, and medical beauty distribution.

According to Butler's company data, cosmetics accounted for about 85% of revenue and healthcare for about 15% based on second-quarter 2026 sales.

The manufacturing arm is Cosleaguer, a wholly owned subsidiary set up at the end of December 2024 as a dermo-cosmetic ODM maker covering masks, skincare, makeup, and body and hair products. The brand arm is the brand operator acquired in 2025, which owns the skincare brand beplain.

Press reports described a model in which the brand operator spots market trends and the manufacturing subsidiary turns them into products quickly. The healthcare arm is Hanchungmedical, which handles export distribution and OEM/ODM for botulinum toxin and fillers.

Press reports said overseas sales reached about 49% of revenue in the first quarter of 2026, and that the manufacturing subsidiary secured a private-label manufacturing supply right with a major Japanese drugstore chain.

In domestic cosmetics ODM competition, production capacity, regulatory registration capability, and the speed of collaboration with brand companies are the key differentiators.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩10.6B-₩2B−19.2%
2025Q4₩9.7B-₩4.2B−43.2%
2026Q1₩39.5B₩1.5B3.9%
2026Q2₩42.4B-₩600M−1.4%
2026Q3₩48.6B₩2.7B5.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩10.1B-₩6.6B-₩6.4B−65.2%−21.2%26.8%
2023₩22.6B-₩7.5B-₩3.3B−33.4%−12.2%38.9%
2024₩19.3B-₩3.3B₩5.4B−17.3%13.8%28.4%
2025₩35.7B-₩8.3B-₩8.7B−23.4%−24.5%476.6%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue went from KRW 10.1 billion in 2022 to KRW 22.6 billion in 2023 (up 123.2%), KRW 19.3 billion in 2024 (down 14.3%), and KRW 35.7 billion in 2025 (up 84.4%). 2025 was the largest year of the 2022–2025 period.

Operating losses were KRW 6.59 billion in 2022, KRW 7.54 billion in 2023, KRW 3.35 billion in 2024, and KRW 8.33 billion in 2025, a loss in all four years, with the 2025 loss widening. The operating margin improved from -65.2% in 2022 to -17.3% in 2024 before slipping to -23.4% in 2025.

That operating losses widened in 2025 even as revenue rose 84.4% shows that the larger top line has not yet translated into profit. Net income attributable to controlling shareholders turned positive in 2024 at KRW 5.38 billion, moving in the opposite direction to the operating loss in the same year.

That gap points to a large influence from items outside operating income, and the specific items are a matter to check in the notes to the annual report. The company returned to a loss in 2025 with a net loss attributable to controlling shareholders of KRW 8.74 billion.

Operating cash flow was negative every year from 2022 to 2025, and the outflow was largest in 2025 at KRW 12.9 billion. At the end of 2025, total liabilities were KRW 187.2 billion against total equity of KRW 39.3 billion, and the debt-to-equity ratio jumped to 476.6% from 28.4% in 2024.

On a quarterly basis, the fourth quarter of 2025 was the low point at KRW 9.72 billion in revenue, followed by KRW 39.5 billion in the first quarter of 2026, KRW 42.4 billion in the second quarter, and KRW 48.6 billion in the third quarter, a run of three consecutive quarterly increases.

Operating results over the same period alternated between profit in the first quarter, loss in the second, and profit in the third. The combined net loss attributable to controlling shareholders over the last four quarters was KRW 12.1 billion.

05

Industry analysis

Cosmetics ODM works on a contract basis, so order flow moves with the growth and channel expansion of the brand owners. The company says it handles registration procedures for major markets, including MFDS, CE, CFDA, CPNP and NMPA, and this capability can act as an entry barrier in overseas expansion.

The company describes Korean beauty's overseas expansion and says it works with partners in China, Southeast Asia, the Middle East, Europe and the United States. On medical beauty, the company says the market is growing steadily and that non-invasive procedures are the main trend.

This is the company's own description and should be checked against external market-size data. The drivers of the company's revenue are best viewed as the consolidation effect of the brand company acquired at the end of 2025 and overseas orders.

Press reports attributed the first-quarter 2026 revenue, which already exceeded full-year 2025 revenue, to the full effect of that acquisition. Against larger domestic ODM players, the company is small, with annual revenue in the hundreds of billions of won range. The structure that places production and brand planning under one group is presented as its differentiator.

06

Outlook

Press reports from May 2026 said the company aims for consolidated revenue of KRW 200 billion in 2026.

When the brand acquisition was announced at the end of 2025, the company presented a blueprint of KRW 190 billion in consolidated 2026 revenue (KRW 60 billion manufacturing, KRW 130 billion brands) and operating profit of at least KRW 15 billion.

Because the two targets differ, which one the company keeps is a point to check. Adding the disclosed revenue for the first three quarters of 2026 gives KRW 130.5 billion, so reaching KRW 200 billion would require roughly KRW 69.5 billion in the fourth quarter.

Operating profit for the same three quarters adds up to KRW 3.68 billion, far below the KRW 15 billion blueprint. Press reports said a new high-function brand, ACTIVINE, was planned for launch during the second quarter of 2026, targeting North America and Mexico.

The Japanese private-label supply right secured by the manufacturing subsidiary is cited as concrete evidence of overseas expansion. The company has said it will keep growing through wider domestic and overseas channels and new brand launches after the second quarter.

However, revenue rose 7.2% in the second quarter yet the company posted an operating loss, so whether growth is now covering selling and administrative costs still needs confirmation in quarterly data.

Quarterly financial data compiled by Google Finance show selling, general and administrative expenses rising from KRW 13.7 billion in the first quarter of 2026 to KRW 17.5 billion in the second quarter. The next checkpoints are therefore the ratio of selling costs to revenue and the direction of the operating margin.

07

Valuation

PER
—
PBR
2.1×
ROE
-29.6%
EPS
-₩700
BPS
₩1,541
Dividend per share
₩0

The share price sits at a premium to book value, with the price-to-book multiple above 1x on the equity attributable to controlling shareholders. An earnings multiple cannot be calculated because the last four quarters were net losses.

The combined net loss attributable to controlling shareholders over those four quarters was KRW 12.1 billion.

The third quarter of 2026 returned to a net profit attributable to controlling shareholders, but profit has not yet held across consecutive quarters, so the price relative to earnings depends on whether quarterly profit stabilizes. Dividends are effectively absent, which limits any dividend-based comparison.

On the capital structure, the debt-to-equity ratio at the end of 2025 was 476.6%, so the financial burden should be read alongside any price-based comparison. This section compares facts only and should be read together with live valuation figures.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Quarterly revenue recovery

Revenue rose from the fourth-quarter 2025 low to KRW 39.5 billion in the first quarter of 2026, KRW 42.4 billion in the second, and KRW 48.6 billion in the third, three consecutive increases. Third-quarter revenue was up 360.3% from a year earlier.

Press reports attributed the top-line lift to the consolidation of the acquired brand company and the manufacturing subsidiary. Operating profit of KRW 2.73 billion in the third quarter is an early sign of the restructuring showing up in the numbers.

Overseas channels and manufacturing capability

Press reports said overseas sales reached about 49% of revenue in the first quarter of 2026. The manufacturing subsidiary was reported to have secured a private-label manufacturing supply right with a major Japanese drugstore chain.

The company says it handles registration in key markets, including MFDS, CE, CFDA, CPNP and NMPA. Having both regulatory registration and production capacity in place is cited as a strength in winning overseas orders.

Brand and manufacturing collaboration

Press reports described a collaboration model in which the brand company reads market trends and the manufacturing subsidiary turns them into products quickly. A new brand, ACTIVINE, was planned for launch in the second quarter of 2026, targeting North America and Mexico.

Combining in-house brands with contract manufacturing is presented as a way to raise utilization of production capacity as order channels widen.

09

Bear factors

Unstable earnings

The company recorded an operating loss in each year from 2022 to 2025, and the 2025 loss widened to KRW 8.33 billion. Despite higher revenue, the second quarter of 2026 returned to an operating loss of KRW 600 million.

The net loss attributable to controlling shareholders was KRW 6.39 billion in that quarter, the largest in the recent five quarters. Profit that does not hold from one quarter to the next weakens confidence in the earnings trend.

Financial burden and cash outflow

At the end of 2025, total liabilities were KRW 187.2 billion against total equity of KRW 39.3 billion, a debt-to-equity ratio of 476.6%, compared with 28.4% in 2024. The increase appears linked to the acquisition and consolidation, but the details need confirmation in the annual report. Operating cash flow was negative every year from 2022 to 2025, reaching KRW -12.9 billion in 2025.

Gap between targets and results

The 2026 consolidated revenue target is KRW 200 billion, while disclosed revenue for the first three quarters totals KRW 130.5 billion, leaving roughly KRW 69.5 billion needed in the fourth quarter.

Operating profit for the first three quarters totals KRW 3.68 billion, far from the earlier blueprint of at least KRW 15 billion. Two different targets have been presented, so which benchmark applies is itself unclear.

10

Risk factors

Financial structure

A debt-to-equity ratio of 476.6% and continued operating cash outflows could increase the need for new financing. Total liabilities of KRW 187.2 billion far exceed total equity of KRW 39.3 billion, adding interest-cost and refinancing exposure. The borrowing schedule and maturity structure in the annual report will show how the burden is managed.

Earnings volatility

Revenue has risen for three consecutive quarters, but operating results moved from profit in the first quarter to loss in the second and profit in the third. Selling and administrative expenses rose from the first to the second quarter, which may mean revenue growth did not absorb the cost increase. Without a steadier cost structure, a run of profitable quarters is harder to sustain.

Overseas operations and regulation

With overseas sales at roughly 49% of revenue, country-specific regulation, exchange rates and reliance on distribution partners carry more weight. The entry of the new brand into North America and Mexico depends on local registration and channel access. A change in orders from a single overseas partner could move quarterly revenue significantly.

11

What to watch next

  1. January–February 2027 (typical timing for preliminary results)

    Preliminary fourth-quarter 2026 results. The checkpoints are whether revenue holds near the third-quarter level of KRW 48.6 billion and whether operating profit continues after the third-quarter profit.

  2. By March 31, 2027 (filing deadline for the 2026 annual report)

    Whether 2026 annual revenue approaches the KRW 200 billion target, whether the debt-to-equity ratio and operating cash flow improve, and what drove the 2025 jump in liabilities.

  3. Late April 2027 (typical timing for first-quarter results)

    Whether overseas revenue share and the new North American and Mexican brand show up in revenue, and whether the selling and administrative cost ratio declines.

12

Overall view

CosLeaguer Global has built a cosmetics-centered structure through the establishment of an ODM subsidiary in December 2024 and the acquisition of a brand company in 2025, and revenue has risen for three consecutive quarters through the third quarter of 2026.

Revenue reached KRW 35.7 billion in 2025, the largest year of the 2022–2025 period, yet the operating loss widened to KRW 8.33 billion and the company has posted operating losses in all four years.

Quarterly operating results in 2026 alternated between profit in the first quarter, loss in the second and profit in the third, so the durability of profit is still at a testing stage.

On the financial side, the debt-to-equity ratio of 476.6% at the end of 2025 and four years of negative operating cash flow remain the largest burdens. Positive factors include a higher overseas revenue share, the Japanese private-label supply right and the collaboration between manufacturing and brands.

Negative factors include earnings volatility, financial burden and the gap between announced targets. The next checkpoints are the preliminary fourth-quarter 2026 results and the 2026 annual report. This report does not present an investment opinion, rating or target price, and it summarizes facts and checkpoints.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. cosleaguerglobal.com
  2. cosleaguerglobal.com
  3. cosleaguerglobal.com
  4. seouleaguer.net
  5. google.com
  6. cosleaguerglobal.com
  7. digitaltoday.co.kr
  8. topstarnews.net
  9. news.nate.com
  10. butler.works
  11. sedaily.com
  12. judal.co.kr
  13. file.myasset.com
  14. judal.co.kr
  15. judal.co.kr
  16. judal.co.kr
  17. judal.co.kr
  18. thebell.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis